Patent Assignment
Reel/Frame 041592/0419
Assignment of Assignor's Interest
Recorded: 2017-03-16
Pages: 4
Assignor
NLS-1 PHARMA AG
Executed: 2016-09-10
Assignee
NLS PHARMA AG
BREITENWEG 10, STANS, 6370, SWITZERLAND
Covered Property
(1)
Phacetoperane for the Treatment of Attention-Deficit Hyperactivity Disorder
Application:
14/360,355 →
Publication:
US 2015/0038533
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.